Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2001-11-30
2008-03-11
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S351000
Reexamination Certificate
active
07341995
ABSTRACT:
The invention relates to the use of SARP-1 for the preparation of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis.
REFERENCES:
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5747639 (1998-05-01), Seely
patent: 5858715 (1999-01-01), Hillman et al.
patent: 6800735 (2004-10-01), Whitty et al.
patent: 7026445 (2006-04-01), LaVallie et al.
patent: 7045596 (2006-05-01), Umansky et al.
patent: 0328255 (1989-08-01), None
patent: WO 9801555 (1998-01-01), None
patent: WO 9813493 (1998-04-01), None
patent: WO 9835043 (1998-08-01), None
Wells, Biochemistry 29:8509-8517, 1990.
Hu et al., Tissue restricted expression of two human Frzbs in preadipocytes and pancreas,Biochemical and Biophysical Research Communications, 247:287-293 (1998).
Ladher et al., Cloning and expression of the Wnt antagonists sfrp-2 and Frzb during chick development,Developmental Biology, 218:183-198 (2000).
Kawakami “Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype”The Journal of Investigative Dermatology110 (1): 47-51 (Jan. 1998).
Abraham et al., “Expression and Function of Surface Antigens on Scleroderma Fibroblasts”Arthritis and Rheumatism, 34 (9): 1164-1172.
Abraham et al., “Expression and Function of Surface Antigens on Scleroderma Fibroblasts”;Arthritis and Rheumatism, 34 (9): 1164-1172, Sep. 1991.
Adler et al., “Allelic Variation at thefrizzledLocus ofDrosopphilia” Molecular Biology Institute and Cancer Center, 8:99-119 (1987); Charlottesville, University of Virginia.
Altschul et al., “Basic Local Alignment Search Tool”;J. Mol. Biol.(1990) 215:403-410; Academic Press Limited.
Altschul et al., Stephen F., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”Nucleic Acids Research(1997) 25 (17): 3389-3402.
Bafico et al., “Interaction of Frizzled Related Protein (FRP) with Wnt Ligands and the Frizzled Receptor Suggests Alternative Mechanisms for FRP Inhibition of Wnt Signaling,”The Journal of Biological Chemistry, 274(23): 16180-16187 (Jun. 4, 1999); The American Society for Biochemistry and Molecular Biology, Inc.
Bányai et al., “The NTR module: Domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases,”Protein Science(1990), 8:1636-1642; Cambridge University Press, USA.
Cavalli et al., “The Stress-Induced MAP Kinase p38 Regulates Endocytic Trafficking via the GDI:Rab5 Comples,”Molecular Cell, 7: 421-432 (Feb. 2000); Cell Press.
Chang et al., “Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium,”Human Molecular Genetics(1999) 8(4): 575-583; Oxford University Press.
Devereux et al., “A comprehensive set of sequence analysis programs for the VAX,”Nucleic Acids Research, 12(1) (1984); Laboratory of Genetics, University of Wisconsin, Madison, WI.
Dimmeler et al., “Oxidized Low-Density Lipoprotein Induces Apoptosis of Human Endothelial Cells by Activation of CPP32-Like Proteases: A Mechanistic Clue to the ‘Response to Injury’ Hypothesis” (Feb. 20, 1997),Molecular Cardiology, Department of Internal Medicinel IV, Univ. of Frankfurt; American Heart Association, Inc.
Finch et al., “Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action,”Proc. Natl. Acad. Sci. USA, 94: 6770-6775 (Jun. 1997).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,”SCIENCE, 286: 531-537 (Oct. 15, 1999).
Grantham, “Amino Acid Formula to Help Explain Protein Evolution”;SCIENCE, 16: 862-864 (Sep. 6, 1974).
Hattori et al., “Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice”;The Journal of Clinical Investigation, 106 (11): 1341-1350 (Dec. 2000).
Krein et al., “Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question,”Expert Opinion, Monthly Focus: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis, pp. 1065-1079; Ashley Publications Ltd., 2001.
Leighton, “Drug Treatment of Scleroderma”;Therapy in Practice, Drugs(2001) 61 (3): 419-427; Adis International Limited.
Leimeister et al., “Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family,”Mechanisms of Development(1998) 75: 29-42; Elsevier Science Ireland Ltd.
Leroy et al., “Increased Collagen Synthesis by Scleroderma Skin Fibroblasts in Vitro,”The Journal of Clinical Investigation54: 880-889 (Oct. 1974).
Lin et al., “The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling,”Proc. Natl. Acad. Sci.USA 94: 11196-11200 (Oct. 1997); The National Academy of Sciences.
Martini et al., “Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis”;Arthritis&Rheumatism, vol. 42, No. 4, Apr. 1999, pp. 807-811; American College of Rheumatology.
McCormick et al., “Anti-TGF-β Treatment Prevents Skin and Lung Fibrosis in Murine Sclerodermatous Graft-Versus-Host Disease: A Model for Human Scleroderma,”The American Association of Immunologists, pp. 5693-5699 (1999).
Melkonyan et al., “SARPs: A family of secreted apoptosis-related proteins,”Proc. Natl. Acad. Sci, USA, 94: 13636-13641 (Dec. 1997); Cell Biology.
Miller et al., “Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways”Oncogene(1999), 18: 7860-7872; Stockton Press, 1999.
Mir et al., “High-efficiency gene transfer into skeletal muscle mediate by electric pulses,”Proc. Natl. Acad. Sci. USA, 96: 4362-4267 (Apr. 1999).
Pearson, “Rapid and Sensitive Sequence Comparison with FASTP and FASTA”Methods in Enzymology183: 63-98; Acedemic Press, Inc. 1990.
Pearson, “Improved tools for biological sequence comparison”;Proc. Natl. Acad. Sci. USA85:2444-2448 (Apr. 1988).
Schumann et al., “Altered Expression of Secreted Apoptosis Related Proteins (SARPs) in Failing Human Myocardium Suggests Autocrine Modulation of Wnt/Frizzled Signaling by Cardiac Overload,”Circulation110(18): 1-759 (Nov. 2, 1999).
Shevchenko et al., “Mass Spectormetric Sequencing of Proteins from Silver-Stained Polycrylamide Gels,”Anal. Chem, (Mar. 1, 1996) 68: 850-858; American Chemical Society.Rattner, Amir, “A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors”; Proc. Natl. Acad. Sci., USA, vol. 94, pp. 2859-.
Shi-Wen et al., “Scleroderma lung fibroblasts exhibit elevated and dysreglated type 1 collagen biosynthesis,”Arthritis&Rheumatism40 (7): 1237-1244 (Jul. 7, 1997); American College of Rheumatology.
Shi-Wen et al., “Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1,”The Journal of Investigative Dermatology(Nov. 22, 2000) 417-425.
Silman, “Mortality from scleroderma in England and Wales 1968-1985,”Annals of the Rheumatic Diseases(1991) 50: 95-96.
Smalley et al., “Wnt signaling in mammalian development and cancer,”Cancer and Metastasis Reviews18: 215-230 (1999); Kluwer Academic Publishers, Netherlands.
Smith et al., “Identification of Common Molecular Subsequences,”J. Mol. Biol.(1981) 147: 195-197.
Strehlow et al., “Biology of the scleroderma fibroblast,”Current Opinion in Rheumatology(1998) 10: 572-578; Lippincott Williams & Wilkins.
Sule et al., “Update on Management of Scleroderma,”Bulletin o
Colinge Jacques
Plater-Zyberk Christine
Power Christine
Browdy and Neimark PLLC
Chandra Gyan
Laboratoires Serono SA
Landsman Robert
LandOfFree
Use of SARP-1 for the treatment and/or prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of SARP-1 for the treatment and/or prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of SARP-1 for the treatment and/or prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3961330